MCM
GILD icon

Mitchell Capital Management’s Gilead Sciences GILD Stock Holding History

Mitchell Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-69,260
Closed -$5.78M – 62
2016
Q2 		$5.78M Sell
69,260
-25,725
-27% -$2.28M 2.31% 24
2016
Q1 		$8.72M Sell
94,985
-36,103
-28% -$3.26M 3% 18
2015
Q4 		$13.3M Buy
131,088
+5,749
+5% +$598K 4.43% 4
2015
Q3 		$12.3M Buy
125,339
+3,166
+3% +$352K 4.3% 7
2015
Q2 		$14.3M Sell
122,173
-38,953
-24% -$4.26M 4.36% 5
2015
Q1 		$15.8M Buy
161,126
+7,457
+5% +$757K 4.88% 2
2014
Q4 		$14.5M Buy
153,669
+1,523
+1% +$158K 4.71% 2
2014
Q3 		$16.2M Buy
152,146
+1,918
+1% +$188K 5.34% 2
2014
Q2 		$12.5M Buy
150,228
+1,890
+1% +$147K 4.19% 4
2014
Q1 		$10.5M Buy
148,338
+4,744
+3% +$372K 3.59% 7
2013
Q4 		$10.8M Sell
143,594
-10,216
-7% -$711K 3.68% 8
2013
Q3 		$9.67M Buy
153,810
+29,180
+23% +$1.74M 3.2% 13
2013
Q2 		$6.39M Buy
+124,630
New +$6.5M 2.37% 24

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mitchell Capital Management's GILD Position: Q3 2016 in Review

Mitchell Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 69,260 shares — an estimated $5.78M sold.

Mitchell Capital Management first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $16.2M in Q3 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Mitchell Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Mitchell Capital Management sold 69,260 Gilead Sciences shares in Q3 2016, an estimated $5.78M.
  • Mitchell Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • Mitchell Capital Management's Gilead Sciences position peaked at $16.2M in Q3 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Mitchell Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.